OxyContin maker Purdue Pharma is set to dissolve and be replaced with a new company operating in the public interest under the settlement of thousands of lawsuits that goes into effect Friday. It’s ...

Purdue Pharma wants a lawsuit dismissed that accuses the company of profiting from the opioid crisis by aggressively marketing OxyContin. The motion to dismiss the suit accuses Massachusetts ...

News broke Monday that Purdue Pharma, the pharmaceutical giant behind the addictive prescription opioid OxyContin, is considering filing for bankruptcy. Such a move could let Purdue off the hook for ...

Purdue Pharma dissolved Friday, enacting its $7.4 billion opioid-related settlement with states across the U.S. Connecticut ...

A judge on Tuesday delayed the criminal sentencing of OxyContin maker Purdue Pharma in order to allow victims to attend the court proceeding in person. U.S. District Judge Madeline Cox Arleo ...

Attorney General Gordon C. Rhea announced Wednesday afternoon that a $7.4 billion settlement reached with Purdue Pharma and its owners, the Sackler family, has become legally effective, capping nearly ...

NEWARK, New Jersey, April 28 (Reuters) - OxyContin maker Purdue Pharma was sentenced on Tuesday to $5.5 billion in fines and penalties stemming from its 2020 guilty plea to charges of deceiving ...

After more than five years of legal twists, bankruptcies and delays, Purdue Pharma was sentenced for fraud Tuesday and ordered to pay $5.54 billion in criminal penalties for its role in fueling the ...